• Title/Summary/Keyword: Metabolic disorder

Search Result 324, Processing Time 0.019 seconds

Relationship between Dietary Intake and Depression in Metabolic Syndroem among Korean Adults: Korea National Health and Nutrition Examination Survey 2014 (대사증후군 환자에서 영양소 섭취 상태와 우울증과의 연관성: 2014년 국민건강영양조사 자료를 이용하여)

  • Kim, Ja-hyung;Han, A Lum;Shin, Sae-Ron;Park, Suh-yeon
    • Journal of agricultural medicine and community health
    • /
    • v.42 no.2
    • /
    • pp.79-86
    • /
    • 2017
  • Objectives: Metabolic syndrome and depression are interconnected disorders. Although many studies have assessed the association between dietary intake and each disorder independently, few studies have examined the association between depression and dietary intake in patients with metabolic syndrome. Our study examined the association between depression and dietary intake in adults with metabolic syndrome. Methods: We analyzed the second data set (2014) from the sixth KNHNES. Of the patients with metabolic syndrome, the final study population comprised 1,334 patients, aged 20 to 60 years, with metabolic syndrome as defined by KNHNES and depression diagnosed by a physician. We examined the patients' dietary intake obtained using the 24-h recollection method in KNHNES. Results: Depression group had a lower niacin dietary intake than those without depression in both male and female (male P=0.047, female P=0.025). None of the other components had any association between depression group and those without depression group in both male and female. Conclusions: This study demonstrates that a low dietary intake of niacin may be related to the depression in patients with metabolic syndrome. The results indicate that it is worthwhile to evaluate the nutritional status in patients who have been diagnosed with both metabolic syndrome and depression.

Tandem Mass Spectrometric Analysis for Disorders in Amino, Organic and Fatty Acid Metabolism : 2 Years of SCL Experience in Korea

  • Yoon, Hye-Ran;Lee, Kyung Ryul
    • Journal of The Korean Society of Inherited Metabolic disease
    • /
    • v.3 no.1
    • /
    • pp.86-93
    • /
    • 2003
  • Background : The SCL began screening of newborns and high risk group blood spots with tandem mass spectrometry (MS/MS) in April 2001. Our goal was to determine approximate prevalence of metabolic disorders, optimization of decision criteria for estimation of preventive effect with early diagnosis. This report describes the ongoing effort to identify more than 30 metabolic disorders by MS/MS in South Korea. Methods : Blood spot was collected from day 2 to 30 (mostly from day 2 to 10) after birth for newborn. Blood spot of high risk group was from the pediatric patients in NICU, developmental delay, mental retardation, strong family history of metabolic disorders. One punch (3.2 mm ID) of dried blood spots was extracted with $150{\mu}L$ of methanol containing isotopically labelled amino acids (AA) and acylcarnitines (AC) internal standards. Butanolic HCl was added and incubated at $65^{\circ}C$ for 15 min. The butylated extract was introduced into the inlet of MS/MS. Neutral loss of m/z 102 and parent ion mode of m/z 85 were set for the analyses of AA and AC, respectively. Diagnosis was confirmed by repeating acylcarnitine profile, urine organic acid and plasma amino acid analysis, direct enzyme assay, or molecular testing. Results : Approximately 31,000 neonates and children were screened and the estimated prevalence (newborn/high risk group), sensitivity, specificity and recall rate amounted to 1:2384/1:2066, 96.55%, 99.98%, and 0.73%, respectively. Confirmed 28 (0.09%) multiple metabolic disorders (newborn/high risk) were as follows; 13 amino acid disorders [classical PKU (3/4), BH4 deficient-hyperphenylalaninemia (0/1), Citrullinemia (1/0), Homocystinuria (0/2), Hypermethioninemia (0/1), Tyrosinemia (1/0)], 8 organic acidurias [Propionic aciduria (2/1), Methylmalonic aciduria (0/1), Isovaleric aciduria (1/1), 3-methylcrotonylglycineuria (1/0), Glutaric aciduria type1 (1/0)], 7 fatty acid oxidation disorders [LCHAD def. (2/2), Mitochondrial TFP def. (0/1), VLCAD def. (1/0), LC3KT def. (0/1). Conclnsion : The relatively normal development of 10 patients with metabolic disorders among newborns (except for the expired) demonstrates the usefulness of newborn screening by MS/MS for early diagnosis and medical intervention. However, close coordination between the MS/MS screening laboratory and the metabolic clinic/biochmical geneticists is needed to determine proper decision of screening parameters, confirmation diagnosis, follow-up scheme and additional tests.

  • PDF

The Effect of Feed Additives Supplement on Prerpartum and Postpartum Feed Intake, Milk Production and Metabolic Disorders of Dairy Cows (전환기 젖소의 사료첨가제 급여가 사료섭취량, 산유량 및 대사성장애 발생에 미치는 영향)

  • Kim, H.S.;Jung, H.Y.;Lee, H.J.;Ki, K.S.;Cho, Y.M.;Ahn, B.S.;Lee, S.S.
    • Journal of Animal Science and Technology
    • /
    • v.44 no.5
    • /
    • pp.561-572
    • /
    • 2002
  • The objective of this study was to evaluate a feed additives used mainly in lactating cow diets in transient pregrent cow diets. The study was conducted as a completely randomized design with forty Holstein pregnant cows to determine the effect of feeding Aspergillus oryzae(T2), Saccharomyces cerevisiae mixture(T3) and enzyme(cellulase, xylanase) - releasing chemicals(ERC) (T4) on the dry matter intake, milk yield, milk composition and metabolic disorders. Dry matter intake was similar among treatments for 3 weeks prepartum but cows fed enzyme tended to increased feed intake compared to no additives treatment both in calving day and for 3 weeks postpartum. Cows fed Aspergillus oryzae, Saccharomyces cerevisiae and ERC produced more milk than those fed no additives. However, there is no significant difference among treatments. Concentration of glucose was not significantly different among treatment prepartum but that in plasma of cows fed ERC was higher at calving and 3 weeks postpartum compared to others. Increase in NEFA began at 3 weeks prepartum and accelerate during the final 7 days before calving at all treatments but lower for ERC-treated cows at calving and 3 weeks postpartum. Ca concentration not different among treatment prepartum and postpartum. Corticoid content decreased significantly for cows fed ERC compared to those fed non-additives. Metabolic disorder was not occurred in cows fed ERC. However, ketosis and displased abomasum were happened 1 cow when fed non-additives, metritis 1 cow when fed Aspergillus oryzae and retained placenta 1 cow in all treatments except cows fed ERC.

Gitelman Syndrome with Normal Serum Magnesium (정상 마그네슘혈증의 Gitelman 증후군 1례)

  • Cheon, Younghee;Seo, Ji Hye;Cheong, Hae Il;Park, Yong Hoon
    • Childhood Kidney Diseases
    • /
    • v.16 no.2
    • /
    • pp.121-125
    • /
    • 2012
  • Gitelman syndrome is an autosomal recessive renal tubular disorder characterized by hypokalemic metabolic alkalosis, and it is distinguished from Batter syndrome by hypomagnesemia and hypocalciuria. This disorder is caused by mutation in SLC12A3 gene which encodes thiazide-sensitive $Na^+-Cl^-$cotransporter (NCCT) which is expressed in the apical membrane of cells, lining distal convoluted tubule. A 8-year old boy who presented with Rolandic epilepsy, and horseshoe kidney accidentally showed clinical features of metabolic alkalosis, hypokalemia, hypocalciuria without hypomagnesemia. So we identified a heterozygote mutation and an abnormal splicing in the SLC12A3 gene, encoding NCCT. The mutation was detected in the exon 15 and 22 of SLC12A3 gene.

A Fatal Case of Neonatal Onset Carbamoyl Phosphate Synthetase I Deficiency with Homozygous CPS1 Mutation (동종 접합자 CPS1 돌연 변이를 동반한 신생아 발병형 Carbamoyl Phosphate Synthetase 1 결핍증의 치명적 사례)

  • Yun, Jung Ha;Shin, Seung Han;Ko, Jung Min;Kim, Ee-Kyung;Kim, Han-Suk
    • Journal of The Korean Society of Inherited Metabolic disease
    • /
    • v.18 no.1
    • /
    • pp.18-22
    • /
    • 2018
  • Carbamoyl phosphate synthetase I (CPS1) deficiency is a rare autosomal recessive urea cycle disorder that causes hyperammonemic crisis. CPS1 is the first enzyme encoded by the CPS1 gene, which catalyzes the first step of the urea cycle. In CPS1 deficiency, ammonia, the toxic metabolite produced by the interruption of the urea cycle, is accumulated in the blood and brain, leading to hyperammonemic encephalopathy and irreversible brain damage. Here, we report a fatal case of neonatal-onset CPS1 deficiency in a 4-day-old girl presenting with recurrent seizures, who was revealed to be homozygous for c.1529delG ($p.Gly510Alafs^*5$).

  • PDF

Major Metabolites Involved in Skin Blackening of 'Niitaka' Pear Stored under Cold Temperature (신고 배 저온 저장 중 발생하는 과피 흑변에 관여하는 주요 대사체)

  • Lee, Eun Jin
    • Horticultural Science & Technology
    • /
    • v.32 no.3
    • /
    • pp.359-365
    • /
    • 2014
  • Oriental pear (Pyrus communis L. cv 'Niitaka') was stored at $0^{\circ}C$ for 5 months and major metabolites involved in blackening of the peel were analyzed by untargeted GC-MS and targeted HPLC methods. In this study, peels of sound and skin-blackened pears were analyzed and compared. Skin-blackened fruit was clearly characterized by a distinctive pattern in changes which included a decrease of malic acid, succinic acid, and ascorbic acid, while an increase of fumaric acid, threonine, and gluconic acid, which indicated both reduced metabolic activity and anti-oxidative capacity of the cells. Chlorogenic acid was a major phenolic compound and the peel of sound fruit showed high levels of free phenolic compounds compared than the peel of skin-blackened fruit which are believed to be related to oxidation of phenolics in skin-blackened tissue. The changes or profiling of major metabolites by targeted or untargeted analysis method could become a useful tool for understanding physiology, disorder mechanism, and identifying metabolic networks connecting primary and secondary metabolism in postharvest research.

DENTAL TREATMENTS OF THE CHILD WITH LOWE SYNDROME : A CASE REPORT (Lowe syndrome 환아의 치과적 치료 : 증례보고)

  • Ju, Chan-Hee;Kim, Seon-Mi;Choi, Nam-Ki
    • Journal of the korean academy of Pediatric Dentistry
    • /
    • v.39 no.2
    • /
    • pp.161-165
    • /
    • 2012
  • Lowe syndrome, also known as oculocerebrorenal syndrome, is a rare genetic disorder involving eyes, kidney, brain and musculoskeletal system, and occurs predominantly in males. The patient with Lowe syndrome is characterized with congenital cataracts, glaucoma, prominent forehead, thin and sparse hair, mental and growth retardation, muscular hypotonia, renal dysfunction, and metabolic bone disease. We have experienced a 10-year-old boy with Lowe syndrome who had poor oral hygiene and trouble for teeth brushing. To manage his behavior and systemic metabolic disorder, sedation was performed during dental care. Excessive calculus formation in this patient is caused by both medication and lack of ability to maintain oral hygiene. The dental management of those patients has to be focused on prevention due to difficulties in dental treatment and dangers of general anesthesia for the Lowe syndrome.

Galactosemia: A Korean Patient and Literature Review (갈락토스 혈증: 한국인 갈락토스 환자 증례보고와 문헌 고찰)

  • Yu, Seung Woo;Gang, Mi Hyeon;Lee, Yong Wook;Chang, Mea Young;Levy, Harvey L.;Kim, Sook Za
    • Journal of The Korean Society of Inherited Metabolic disease
    • /
    • v.20 no.1
    • /
    • pp.14-23
    • /
    • 2020
  • Classic galactosemia is a rare genetic disorder in Korea and the mutation spectrum in Koreans differs from that of Caucasians and non-Caucasian Americans. Classic galactosemia is considered a metabolic complication that is preventable by early detection via newborn screening and dietary treatment. In this most recent case of Korean galactosemia, the patient showed early initiation of clinical symptoms, which manifested during the neonatal period. The patient achieved normalization via diet management to correct metabolic complications. In addition, we assessed the characteristics of mutations in 25 Korean galactosemia cases via a literature review of studies associated with classic galactosemia.

Pamidronate therapy for a Patient with Methylmalonic acidemia (메틸말론산혈증 환자에서 파미드로네이트 치료 1례)

  • Cho, Sujin;Seo, Go Hun;Kim, Yoon-Myung;Kim, Gu-Hwan;Yoo, Han-Wook;Lee, Beom Hee
    • Journal of The Korean Society of Inherited Metabolic disease
    • /
    • v.18 no.1
    • /
    • pp.13-17
    • /
    • 2018
  • Methylmalonic acidemia is an autosomal recessive disorder caused by complete (mut0) or partial (mut-) deficiency of methylmalonyl-CoA mutase (MUT) or by defects in the synthesis of adenosylcobalamin (cblA, cblB, cblD variant 2). Long term complications of methylmalonic acidemia include tubulointerstitial nephritis with progressive renal failure, intellectual impairment, pancreatitis, and growth failure. We report a case of methylmalonic acidemia in a girl who diagnosed at 6 days after birth. She has developed recurrent metabolic crises with hyperammonemia and metabolic acidosis. In addition, she suffered from the chronic complications including tubulointerstitial nephritis, electrolyte imbalance associated with renal dysfunction, growth failure and fracture of femur shaft. At the age of 10 years, hypercalcemia and severe osteoporosis were noted, and pamidronate therapy was given for two years, which relieved hypercalcemia and osteoporosis.

  • PDF

A Neonate with Alpha-methylacetoacetic Aciduria Identified by Newborn Screening (신생아 스크리닝으로 진단된 Alpha-methylacetoacetic Aciduria 증례)

  • Lee, Beom Hee;Kim, Yoo-Mi;Kim, Jae-Min;Kim, Gu-Hwan;Yoo, Han-Wook
    • Journal of The Korean Society of Inherited Metabolic disease
    • /
    • v.12 no.2
    • /
    • pp.104-107
    • /
    • 2012
  • Alpha-methylacetoacetic aciduria is a rare inborn metabolic disorder, caused by acetyl-CoA acetyltransferase-1 deficiency. This enzyme acts on the last step of isoleucine metabolism. It dissociates 2-Methyl-3-Hydroxybutyryl-CoA into propionyl-CoA and acetyl-CoA. ACAT1 is the causative gene. Most patients manifest recurrent ketotic metabolic acidosis, but some patients can be identified in their presymptomatic period by newborn screening. Urinary organic acid profile is characterized by increased amounts of 2-Methyl-3-Hydroxybutyric acid, tiglylglycine, and 2-methyl acetoacetic acid. In this report, a Korean patient with alpha-methylacetoacetic aciduria is described. This is the first Korean case report confirmed by genetic testing.

  • PDF